Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
136.51
-2.12 (-1.53%)
At close: Dec 5, 2025, 4:00 PM EST
136.02
-0.49 (-0.36%)
After-hours: Dec 5, 2025, 7:39 PM EST

TransMedics Group Revenue

TransMedics Group had revenue of $143.82M in the quarter ending September 30, 2025, with 32.24% growth. This brings the company's revenue in the last twelve months to $566.35M, up 41.20% year-over-year. In the year 2024, TransMedics Group had annual revenue of $441.54M with 82.74% growth.

Revenue (ttm)
$566.35M
Revenue Growth
+41.20%
P/S Ratio
8.16
Revenue / Employee
$777,959
Employees
728
Market Cap
4.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 30, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

TMDX News

More News